Xiu-ying Xiao

No. 160 Pujian Road
Shanghai, 200127, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

NSD2 inhibits the expression of PD-L1 via oxidative phosphorylation to control immune surveillance in hepatocellular carcinoma.

NSD2 inhibits the expression of PD-L1 via oxidative phosphorylation to control immune surveillance in hepatocellular carcinoma.

Journal: Cell death & disease

Published: July 19, 2025

Tumor-derived CCL5 recruits CCR1+ macrophages to suppress apoptosis and drive proliferation in duodenal adenocarcinoma.

Tumor-derived CCL5 recruits CCR1+ macrophages to suppress apoptosis and drive proliferation in duodenal adenocarcinoma.

Journal: Cancer letters

Published: June 03, 2025

Surufatinib plus paclitaxel as second-line therapy for advanced gastric cancer: a single-arm, phase 2 clinical trial.

Surufatinib plus paclitaxel as second-line therapy for advanced gastric cancer: a single-arm, phase 2 clinical trial.

Journal: Cellular oncology (Dordrecht, Netherlands)

Published: May 06, 2025

The antibody-drug conjugate SHR-A1904 for targeting CLDN18.2 in advanced gastric or gastroesophageal junction cancer: a phase 1 trial.

The antibody-drug conjugate SHR-A1904 for targeting CLDN18.2 in advanced gastric or gastroesophageal junction cancer: a phase 1 trial.

Journal: Nature medicine

Published: January 22, 2025

Screening of patient-derived organoids identifies mitophagy as a cell-intrinsic vulnerability in colorectal cancer during statin treatment.

Screening of patient-derived organoids identifies mitophagy as a cell-intrinsic vulnerability in colorectal cancer during statin treatment.

Journal: Cell reports. Medicine

Published: September 22, 2024

Interplay between gut microbial communities and metabolites modulates pan-cancer immunotherapy responses.

Interplay between gut microbial communities and metabolites modulates pan-cancer immunotherapy responses.

Journal: Cell metabolism

Published: April 14, 2024

Predictive value of positive lymph node ratio in patients with locally advanced gastric remnant cancer.

Predictive value of positive lymph node ratio in patients with locally advanced gastric remnant cancer.

Journal: World journal of gastrointestinal oncology

Published: October 11, 2023

Gut microbiome for predicting immune checkpoint blockade-associated adverse events.

Gut microbiome for predicting immune checkpoint blockade-associated adverse events.

Journal: Genome medicine

Published: March 08, 2023

Faecalibacterium prausnitzii Abrogates Intestinal Toxicity and Promotes Tumor Immunity to Increase the Efficacy of Dual CTLA4 and PD-1 Checkpoint Blockade.

Faecalibacterium prausnitzii Abrogates Intestinal Toxicity and Promotes Tumor Immunity to Increase the Efficacy of Dual CTLA4 and PD-1 Checkpoint Blockade.

Journal: Cancer research

Published: February 24, 2023

Correction to: Colorectal cancer organoid models uncover oxaliplatin-resistant mechanisms at single cell resolution.

Correction to: Colorectal cancer organoid models uncover oxaliplatin-resistant mechanisms at single cell resolution.

Journal: Cellular oncology (Dordrecht, Netherlands)

Published: November 24, 2022

Fusobacterium nucleatum-derived succinic acid induces tumor resistance to immunotherapy in colorectal cancer.

Fusobacterium nucleatum-derived succinic acid induces tumor resistance to immunotherapy in colorectal cancer.

Journal: Cell host & microbe

Published: August 11, 2022

Colorectal cancer organoid models uncover oxaliplatin-resistant mechanisms at single cell resolution.

Colorectal cancer organoid models uncover oxaliplatin-resistant mechanisms at single cell resolution.

Journal: Cellular oncology (Dordrecht, Netherlands)

Published: April 21, 2022

Showing 1-12 of 18

Last Updated: 09/26/2026